Medical Developments International has released a press release.
Medical Developments to take control of EU markets
Filed with ASX ·
Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19Read the transcript of Medical Developments International (ASX:MVP) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Medical Developments International Limited on 6ix
Earlier from Medical Developments International
- S&P DJI Announces June 2020 Quarterly Rebalance
- Penthrox approved in Hungary
- Penthrox approved - Netherlands and Bosnia and Herzegovina
- Penthrox is approved in Thailand
- COVID-19 Impact on MVP
Later from Medical Developments International
- Appointment of Non-Executive Director - Gordon Naylor
- Appointment of CEO - Brent MacGregor
- Chairmans and CEOs Address to Shareholders
- MVP and MundiPharma cease Australian licensing agreement
- EU Transition and Trading Update
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International